Uso de agentes antipsicóticos y enfermedad tromboembólica venosa recurrente

Ishiguro C,Wang X, Li L, et al. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD. Pharmacoepidemiol Drug Saf. 2014; 23:1168-75. DOI: https://doi.org/10.1002/pds.3699

Ferraris A, Szmulewicz AG, Vázquez FJ, et al. Antipsychotic use among adult outpatients and venous thromboembolic disease: a retrospective cohort study. J Clin Psychopharmacol. 2017; 37(4):405-11. DOI: https://doi.org/10.1097/JCP.0000000000000738

Mollard LM, Le Mao R, Tromeur C, et al. Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study. Eur J Intern Med. 2018; 52:22-27. DOI: https://doi.org/10.1016/j.ejim.2018.02.030

Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ. 2010; 341:c4245. DOI: https://doi.org/10.1136/bmj.c4245

Schmedt N, Garbe E. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia. J Clin Psychopharmacol. 2013; 33:753-8. DOI: https://doi.org/10.1097/JCP.0b013e3182a412d5

Wu CS, Lin CC, Chang CM, et al. Antipsychotic treatment and the occurrence of venous thromboembolism: a 10-year nationwide registry study. J Clin Psychiatry. 2013; 4:918-24. DOI: https://doi.org/10.4088/JCP.12m08117